Hambly R J, Double J A, Thompson M J, Bibby M C
Clinical Oncology Unit, University of Bradford, West Yorkshire, UK.
Breast Cancer Res Treat. 1997 May;43(3):247-58. doi: 10.1023/a:1005756632293.
Human breast cancer cell lines are required as models for use in the understanding of breast carcinoma, and for improving the ability of cell screens to detect appropriate anti-cancer agents. Four human breast cancer cell lines (MT-1, MaTu. MT-3 and MC4000) were established from human tumour xenografts grown in nude mice. All the lines were shown to be of human origin by karyotype analysis, were epithelial in morphology by both light and electron microscopy, were positive for cytokeratin 18, and were free from mycoplasma, bacterial, yeast and fungal contamination. All of the new lines were shown to be ER and PgR negative, while using the same procedures (i.e. radioligand binding and immunohistochemical staining) the positive control cell line MCF-7 was shown to be positive. MaTu had been previously reported as ER and PgR positive in vivo and it may be that this characteristic had been lost due to in vitro selection pressures. The growth rates of all the new breast cancer cell lines were similar and within the limits required for incorporation into a panel for screening anti-cancer drugs by a microtetrazolium based, colorimetric growth inhibition assay. Three of the lines (MT-1. MaTu and MC4000) were also able to grow into macroscopic colonies for use in a non-agar clonogenic assay. In addition, both MT-1 and MaTu formed spheroids and were clonogenic in soft-agar. The new lines demonstrated a wide range of sensitivities to anticancer agents commonly used in the treatment of breast cancer, and together with their corresponding xenografts are providing additional systems for the evaluation of new compounds.
人类乳腺癌细胞系是用于理解乳腺癌以及提高细胞筛选检测合适抗癌药物能力的模型。四种人类乳腺癌细胞系(MT-1、MaTu、MT-3和MC4000)是从在裸鼠体内生长的人肿瘤异种移植瘤中建立的。通过核型分析表明所有细胞系均起源于人类,光镜和电镜观察其形态均为上皮样,细胞角蛋白18呈阳性,且无支原体、细菌、酵母和真菌污染。所有新细胞系均显示雌激素受体(ER)和孕激素受体(PgR)阴性,而采用相同方法(即放射性配体结合和免疫组织化学染色)时,阳性对照细胞系MCF-7呈阳性。MaTu先前报道在体内ER和PgR呈阳性,可能由于体外选择压力而丧失了这一特性。所有新乳腺癌细胞系的生长速率相似,且在通过基于微量四氮唑的比色生长抑制试验纳入抗癌药物筛选细胞组所需的范围内。其中三个细胞系(MT-1、MaTu和MC4000)也能够生长形成肉眼可见的集落,用于非琼脂克隆形成试验。此外,MT-1和MaTu均能形成球体且在软琼脂中具有克隆形成能力。这些新细胞系对乳腺癌治疗中常用的抗癌药物表现出广泛的敏感性,并且与它们相应的异种移植瘤一起为评估新化合物提供了额外的系统。